Roelmi presents a study that assess the ability of a probiotic formulation containing Lactobacillus plantarum PBS067, Lactobacillus acidophilus PBS066 and Lactobacillus reuteri PBS072 to exert a positive effect on metabolic syndrome by improving body circumference, lipid metabolic profile, chronic inflammation and overall quality of life.
